Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis.
10.1016/j.apsb.2023.08.016
- Author:
Wenjing YU
1
;
Yuehuai HU
1
;
Zhiping LIU
2
;
Kaiteng GUO
1
;
Dinghu MA
1
;
Mingxia PENG
1
;
Yuemei WANG
1
;
Jing ZHANG
1
;
Xiaolei ZHANG
1
;
Panxia WANG
1
;
Jiguo ZHANG
3
;
Peiqing LIU
1
;
Jing LU
1
Author Information
1. National and Local United Engineering Lab of Druggability and New Drugs Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
2. School of Pharmacy, Jinan University, Guangzhou 510632, China.
3. School of Pharmaceutical Sciences, Shandong First Medical University & Shangdong Academy of Medical Sciences, Taian 271016, China.
- Publication Type:Journal Article
- Keywords:
Cardiomyopathy;
Cell death;
Doxorubicin;
Ferroptosis;
Iron homeostasis;
Mitochondria;
SNX3;
TFRC
- From:
Acta Pharmaceutica Sinica B
2023;13(12):4875-4892
- CountryChina
- Language:English
-
Abstract:
The clinical utilization of doxorubicin (Dox) in various malignancies is restrained by its major adverse effect: irreversible cardiomyopathy. Extensive studies have been done to explore the prevention of Dox cardiomyopathy. Currently, ferroptosis has been shown to participate in the incidence and development of Dox cardiomyopathy. Sorting Nexin 3 (SNX3), the retromer-associated cargo binding protein with important physiological functions, was identified as a potent therapeutic target for cardiac hypertrophy in our previous study. However, few study has shown whether SNX3 plays a critical role in Dox-induced cardiomyopathy. In this study, a decreased level of SNX3 in Dox-induced cardiomyopathy was observed. Cardiac-specific Snx3 knockout (Snx3-cKO) significantly alleviated cardiomyopathy by downregulating Dox-induced ferroptosis significantly. SNX3 was further demonstrated to exacerbate Dox-induced cardiomyopathy via induction of ferroptosis in vivo and in vitro, and cardiac-specific Snx3 transgenic (Snx3-cTg) mice were more susceptible to Dox-induced ferroptosis and cardiomyopathy. Mechanistically, SNX3 facilitated the recycling of transferrin 1 receptor (TFRC) via direct interaction, disrupting iron homeostasis, increasing the accumulation of iron, triggering ferroptosis, and eventually exacerbating Dox-induced cardiomyopathy. Overall, these findings established a direct SNX3-TFRC-ferroptosis positive regulatory axis in Dox-induced cardiomyopathy and suggested that targeting SNX3 provided a new effective therapeutic strategy for Dox-induced cardiomyopathy through TFRC-dependent ferroptosis.
